October in review: GLP-1 nutrition, pharma-grade supplements & Abbott spin-off
GLP-1 companion nutrition, microbiome science, and product substantiation continued to dominate the nutrition industry last month. We explored new opportunities at industry events in longevity and women’s and metabolic health. In our October review, Nutrition Insight explores some of the month’s biggest stories, with industry experts urging GLP-1 companion nutrition complementing drugs and stronger clinical evidence for menopause supplements. Exhibitors at CPHI Milan 2026, Italy, highlighted pharmaceutical standards as a growing priority for nutraceutical manufacturers. At SupplySide Global 2026 in Las Vegas, Nevada, US, companies showcased innovations in women’s health, longevity, and the gut microbiome.This Technical paper is brought to you by Saanroo.
At SupplySide Global 2026 in Las Vegas, Nevada, US, exhibitors told Nutrition Insight that metabolic, women’s, and gut health, alongside longevity, will shape product innovation in 2027. GLP-1s are driving companion nutrition, while the healthy aging trend is fueling innovation in products aimed at specific life stages. Companies also said consumers are seeking multifunctional solutions in fun formats and pointed toward opportunities in mood support and sustained energy.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position

Latest headlines

Next-gen supplements Nov 2026

Brain health supplement boostersNov 2026
Multimedia
At SupplySide Global 2026 in Las Vegas, Nevada, US, exhibitors told Nutrition Insight that metabolic, women’s, and gut health, alongside longevity, will shape product innovation in 2027. GLP-1s are driving companion nutrition, while the healthy aging trend is fueling...

































